TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30477763

Group type: EXPERIMENTAL
Intervention: High-dose subcutaneous treprostinil (target dose around 30 ng/kg per min at week 12)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Low-dose subcutaneous treprostinil (target dose around 3 ng/kg per min at week 12)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Comparison of high-dose vs low-dose subcutaneous treprostinil
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: High-dose subcutaneous treprostinil
Number of subjects: 105

Group type: COMPARATOR
Intervention: Low-dose subcutaneous treprostinil
Number of subjects: 105
Study: 26919407

Group type: EXPERIMENTAL
Intervention: Cavuplasty (creating a small cavity in the vertebral body prior to cement injection)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vertebroplasty (control)
Number of subjects: 36
Study: 27385833

Group type: EXPERIMENTAL
Intervention: Two consecutive real cervical spinal manipulative therapy (SMT) interventions to C5‐C6 segment
Number of subjects: 26

Group type: COMPARATOR
Intervention: One real SMT followed by one validated sham SMT intervention to C5‐C6 segment
Number of subjects: 26
Study: 25103358

Group type: EXPERIMENTAL
Intervention: EASY Minds program (curriculum-based physical activity integration program)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 8
Study: 21936966

Group type: COMPARATOR
Intervention: Selenomethionine (SeMet) supplementation at doses of 0, 50, 100, or 200 μg/d
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Selenomethionine (SeMet) supplementation
Number of subjects: 261
Study: 19092145

Group type: EXPERIMENTAL
Intervention: Intensive glucose control (target glycated hemoglobin reduction of 1.5 percentage points)
Number of subjects: 1791

Group type: COMPARATOR
Intervention: Standard glucose control (mean glycated hemoglobin level 8.4%)
Number of subjects: 1791

Group type: EXPERIMENTAL
Intervention: Intensive glucose control
Number of subjects: 1791

Group type: COMPARATOR
Intervention: Standard glucose control
Number of subjects: 1791
Study: 17600165

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior treatment (CBT)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 140
Study: 15679008

Group type: EXPERIMENTAL
Intervention: Automatic CPAP (AutoSet T, ResMed, Sydney, Australia)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fixed level CPAP
Number of subjects: 20
Study: 11464715

Group type: EXPERIMENTAL
Intervention: TNF-alpha levels in cerebrospinal fluid and serum in patients with stroke
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (15 patients with tension headache and neurasthenia)
Number of subjects: 30
Study: 9972055

Group type: EXPERIMENTAL
Intervention: Renal artery embolization
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Patients with renal cancer before embolization
Number of subjects: 45
Study: 8145914

Group type: EXPERIMENTAL
Intervention: 2.0 mg Dihydroergotamine (DHE) nasal spray (0.5 mg per nostril, repeated after 15 minutes)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 3062540

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine solution 0.5% (1 drop 3 times daily)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo vehicle solution
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine solution 0.5%
Number of subjects: 118
Study: 31734805

Group type: EXPERIMENTAL
Intervention: Unilateral‐Approach group
Number of subjects: 71

Group type: COMPARATOR
Intervention: Bilateral‐Approach group
Number of subjects: 71
Study: 31407622

Group type: EXPERIMENTAL
Intervention: Pushen capsule
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ginkgo biloba
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Pushen capsule and Ginkgo biloba
Number of subjects: 70
Study: 29148175

Group type: EXPERIMENTAL
Intervention: Probiotic cocktail (Lactobacilli, Bifidobacteria, and Streptococcus thermophilus) once daily for 12 weeks
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Probiotic cocktail
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (low-fat/low-calorie diet only)
Number of subjects: 75
Study: 25846824

Group type: EXPERIMENTAL
Intervention: Activities of daily living (ADL) score <12 of 15
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Braden Scale score <16
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: ADL score <12 of 15
Number of subjects: 734
Study: 23452547

Group type: EXPERIMENTAL
Intervention: Subsidized pre-packaged artemether-lumefantrine (AL) with training for retail staff
Number of subjects: 564
Study: 21894687

Group type: EXPERIMENTAL
Intervention: Eye acupuncture therapy
Number of subjects: 110

Group type: COMPARATOR
Intervention: Ibuprofen Sustained Release Capsules, 300 mg orally, 1-2 days before menses or when symptoms appeared, every 12 hours for 3-5 days
Number of subjects: 110
Study: 19250683

Group type: EXPERIMENTAL
Intervention: Citalopram (SSRI)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Reboxetine (NaRI)
Number of subjects: 108
Study: 16739330

Group type: EXPERIMENTAL
Intervention: High-dose neoadjuvant treatment with cyclophosphamide and epirubicin
Number of subjects: 37
Study: 15324983

Group type: EXPERIMENTAL
Intervention: Perimenopausal health education intervention (health education brochure, one-on-one teaching)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 353
Study: 11511713

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (Viagra) 50 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 9012686

Group type: EXPERIMENTAL
Intervention: rHuG‐CSF (Lenograstim) 2.5 micrograms/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rHuG‐CSF (Lenograstim) 5.0 micrograms/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rHuG‐CSF (Lenograstim) 7.5 micrograms/kg
Number of subjects: 0
Study: 8453943

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 81
Study: 3862426

Group type: EXPERIMENTAL
Intervention: Epostane
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31692559

Group type: EXPERIMENTAL
Intervention: DemenTalent (part of iMCSP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DemenTalent and regular MCSP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dementelcoach (part of iMCSP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: STAR e‐Learning (part of iMCSP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regular MCSP
Number of subjects: 0

Group type: COMPARATOR
Intervention: No day care support
Number of subjects: 0
Study: 29269513

Group type: EXPERIMENTAL
Intervention: BMS‐986120 (60 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Aspirin (600 mg)
Number of subjects: 40
Study: 25939641

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking + facilitated tucking
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Oral sucrose + facilitated tucking
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking + oral sucrose
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking + oral sucrose + facilitated tucking
Number of subjects: 110
Study: 24211236

Group type: EXPERIMENTAL
Intervention: Total Sleep Deprivation (TSD)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal night sleep
Number of subjects: 12
Study: 21458326

Group type: EXPERIMENTAL
Intervention: IRM (Intermediate Restorative Material)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Super-EBA (Super Ethoxybenzoic Acid)
Number of subjects: 164
Study: 19406976

Group type: EXPERIMENTAL
Intervention: 400 mg phosphorus meal
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 1200 mg phosphorus meal
Number of subjects: 11
Study: 17446813

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 12253
Study: 15123865

Group type: EXPERIMENTAL
Intervention: Partial exchange transfusion using isotonic saline within 4 hours of screening
Number of subjects: 45

Group type: COMPARATOR
Intervention: Routine medical management
Number of subjects: 45
Study: 11773672

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (specific intervention not detailed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional drug development model (implied control)
Number of subjects: 0
Study: 8055894

Group type: EXPERIMENTAL
Intervention: Glucose (75 g)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Fructose (75 g)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (W)
Number of subjects: 11
Study: 3143239

Group type: EXPERIMENTAL
Intervention: Iopamidol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Iohexol
Number of subjects: 40
Study: 31049205

Group type: EXPERIMENTAL
Intervention: Clinical deprescribing trials
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Barriers to conducting deprescribing trials
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Enablers of conducting deprescribing trials
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Methodology for deprescribing trials
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Need for clinical practice framework
Number of subjects: 96

Group type: COMPARATOR
Intervention: Previous experience in conducting deprescribing trials
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Future deprescribing trial framework
Number of subjects: 96
Study: 28549436

Group type: EXPERIMENTAL
Intervention: Cross-linked sodium hyaluronate (XLHA, single injection)
Number of subjects: 287

Group type: COMPARATOR
Intervention: High molecular weight sodium hyaluronate (HMWHA, three injections)
Number of subjects: 287
Study: 25245307

Group type: EXPERIMENTAL
Intervention: Weight loss intervention based on portion-controlled meals
Number of subjects: 41

Group type: COMPARATOR
Intervention: Delayed-treatment control
Number of subjects: 41
Study: 23078531

Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise (4 times/week, 60 min/session, 60-75% of maximum heart rate)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Resistance training (60-80% baseline maximum load achieved in one repetition)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combined aerobic exercise plus resistance training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (self-controlled exercise)
Number of subjects: 100
Study: 20817790

Group type: EXPERIMENTAL
Intervention: Family oriented intervention involving family members in care, including family counselling during clinic visits, family meetings, and home visits.
Number of subjects: 243

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 243
Study: 18555517

Group type: EXPERIMENTAL
Intervention: Infusion of activated autologous T cells
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (healthy age-matched controls)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 103
Study: 17031403

Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2) group; received four doses of 10 x 10(6) IU m(‐2) twice daily subcutaneously a week before operation followed by a daily maintenance dose of 3 x 10(6) IU m(‐2) subcutaneously until a day before the operation.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group; perioperative immunomonitoring without immunomodulation.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2) group; received IL-2 treatment.
Number of subjects: 120
Study: 15334869

Group type: EXPERIMENTAL
Intervention: Oral glutamine (10 grams three times a day for 5 days)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (identical-appearing)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Oral glutamine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 10845968

Group type: EXPERIMENTAL
Intervention: Interventions to change professional practice in primary care; specific details on dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental designs for interventions; specific details not available.
Number of subjects: 0
Study: 9402502

Group type: EXPERIMENTAL
Intervention: Various interventions for dentine hypersensitivity (specific interventions not detailed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Benchmark control
Number of subjects: 0
Study: 7710841

Group type: EXPERIMENTAL
Intervention: Dual-energy X-ray absorptiometry (DEXA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: In vivo neutron activation analysis (IVNAA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Transfusion treatment
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Osteopenic condition
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: DEXA
Number of subjects: 50
Study: 3236318

Group type: EXPERIMENTAL
Intervention: Amiloride 5 mg once daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amiloride 10 mg once daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg once daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg twice daily
Number of subjects: 12
Study: 29307549

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 3378

Group type: COMPARATOR
Intervention: No Statins (Control)
Number of subjects: 3378
Study: 27134051

Group type: EXPERIMENTAL
Intervention: Micro Expression Training Tool (METT)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Subtle Expression Training Tool (SETT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 82
Study: 25526733

Group type: EXPERIMENTAL
Intervention: Everolimus (70 mg/wk) with temozolomide and radiotherapy
Number of subjects: 100
Study: 23262585

Group type: EXPERIMENTAL
Intervention: Exogenous glucagon
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reduction of Fgf-21 expression (by approximately 66%) or immunoneutralisation of released FGF-21
Number of subjects: 0
Study: 21986640

Group type: EXPERIMENTAL
Intervention: Dietary intake of saturated fat and cheese
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Dietary intake of isoflavonoids and soy
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Dietary intake of total fat and monounsaturated fat
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Alcohol intake
Number of subjects: 92
Study: 18512581

Group type: EXPERIMENTAL
Intervention: Preceptor education program
Number of subjects: 0
Study: 17156464

Group type: EXPERIMENTAL
Intervention: Acupuncture (up to 10 treatments over 3 months)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual GP care alone
Number of subjects: 24
Study: 14535967

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 390

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 390
Study: 10933361

Group type: EXPERIMENTAL
Intervention: Omapatrilat
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Omapatrilat (high dose)
Number of subjects: 48
Study: 8881639

Group type: EXPERIMENTAL
Intervention: Bair Hugger
Number of subjects: 30

Group type: COMPARATOR
Intervention: Thermomat
Number of subjects: 30
Study: 8299252

Group type: EXPERIMENTAL
Intervention: Intermittent high-dose pulse cyclophosphamide (Cy) and oral prednisone
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Daily oral low-dose cyclophosphamide (Cy) and oral prednisone
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: High-dose co-trimoxazole therapy
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 23
Study: 3032814

Group type: EXPERIMENTAL
Intervention: Intramuscular iodinated oil given before conception
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular iodinated oil
Number of subjects: 0
Study: 29230878

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) - Dexcom G5
Number of subjects: 40

Group type: COMPARATOR
Intervention: Flash Glucose Monitoring - Abbott Freestyle Libre
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CGM
Number of subjects: 40
Study: 27492521

Group type: EXPERIMENTAL
Intervention: Endobronchial valve treatment
Number of subjects: 43

Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 43
Study: 24013441

Group type: EXPERIMENTAL
Intervention: RIX4414 vaccine
Number of subjects: 3333

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3333
Study: 22915277

Group type: EXPERIMENTAL
Intervention: Self-set goal for final balance (n=25)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Presentation of an anchor (n=25)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Anchor and goal definition (n=25)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Neither anchor nor goal setting (n=25)
Number of subjects: 100
Study: 21055140

Group type: EXPERIMENTAL
Intervention: Elastic bandage group (ER)
Number of subjects: 2910

Group type: EXPERIMENTAL
Intervention: T band group (TB)
Number of subjects: 2910

Group type: EXPERIMENTAL
Intervention: Balloon group (TR)
Number of subjects: 2910
Study: 18487889

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC) training
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control training (axial exercises, balance awareness/education, stress reduction)
Number of subjects: 19
Study: 15990748

Group type: EXPERIMENTAL
Intervention: Rate-control strategy
Number of subjects: 4060

Group type: COMPARATOR
Intervention: Rhythm-control strategy
Number of subjects: 4060
Study: 12922040

Group type: EXPERIMENTAL
Intervention: Ultra-early decompressive craniectomy (less than 6 hours)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Craniectomy beyond 6 hours
Number of subjects: 52

Group type: COMPARATOR
Intervention: No operation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Diagnosis by CT
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Diagnosis by DWI
Number of subjects: 52
Study: 10737271

Group type: EXPERIMENTAL
Intervention: Large amplitude (30 cm)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Medium amplitude (22.5 cm)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Small amplitude (15 cm)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Practice
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Transfer tests
Number of subjects: 3
Study: 8853757

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole daily for 9 days
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 40 mg omeprazole daily for 9 days
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Long-term therapy with omeprazole (mean duration 56 months) in GERD patients
Number of subjects: 33
Study: 1735850

Group type: EXPERIMENTAL
Intervention: Synthetic surfactant Exosurf Neonatal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 0
Study: 3883917

Group type: EXPERIMENTAL
Intervention: Etretinate (Tigason) up to 0.5 mg/kg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 20
Study: 30153464

Group type: EXPERIMENTAL
Intervention: 13-min daily guided meditation session for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: 13-min daily podcast listening session (control group) for 8 weeks
Number of subjects: 0
Study: 29397160

Group type: EXPERIMENTAL
Intervention: Dietary counseling intervention
Number of subjects: 554
Study: 27221676

Group type: EXPERIMENTAL
Intervention: Medial canthal vertical incision
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Subciliary incision
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Prolene 6‐0 suture
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vicryl 6‐0 suture
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pediatric patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dark-skinned patients
Number of subjects: 40
Study: 24270743

Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin I (cTnI) Stratus CS
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin I (cTnI) Beckmann
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin I (cTnI) Siemens ultra
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin T
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Heart fatty acid binding protein (HFABP)
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Copeptin
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Combination of HFABP and troponin
Number of subjects: 850
Study: 22095207

Group type: EXPERIMENTAL
Intervention: Standard rehabilitation plus NMES applied to the quadriceps muscle, initiated 48 hours after surgery, applied twice per day at maximum tolerable intensity for 15 contractions.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard rehabilitation (control).
Number of subjects: 66
Study: 20393696

Group type: EXPERIMENTAL
Intervention: Glycyrrhizin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 18663117

Group type: EXPERIMENTAL
Intervention: Ultrasound (1 MHz, 0.5 W/cm(2)) once daily, six times a week for seven weeks (Groups 1 and 3)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (Group 4)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Surgical treatment (Groups 1 and 2)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Conservative treatment with ultrasound (Group 3)
Number of subjects: 81
Study: 16351668

Group type: EXPERIMENTAL
Intervention: EZE/SIMVA 10/20 mg/day
Number of subjects: 435

Group type: COMPARATOR
Intervention: ATV 20 mg/day
Number of subjects: 435
Study: 11915724

Group type: EXPERIMENTAL
Intervention: Extended lymphatic and connective tissue clearance during surgical resection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extended surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgery combined with chemo- and/or radiation therapies
Number of subjects: 0
Study: 10342337

Group type: EXPERIMENTAL
Intervention: Humalog insulin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Human soluble insulin
Number of subjects: 20